Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  8, 179 - 183 (2002)
doi:10.1038/nm0202-179


There is an Erratum (March 2002) associated with this Article.

Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity

Ellen L. Air1, 5, Mathias Z. Strowski2, 5, Stephen C. Benoit3, Stacey L. Conarello2, Gino M. Salituro4, Xiao-Ming Guan2, Kun Liu3, Stephen C. Woods3 & Bei B. Zhang2

1  Departments of Biomedical Sciences and Cell Biology, Neurobiology and Anatomy, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA

2  Department of Molecular Endocrinology and Metabolic Disorders, Merck Research Laboratories, Rahway, New Jersey, USA

3  Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA

4  Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, New Jersey, USA

5  E.L.A. and M.Z.S. contributed equally to this paper.

Correspondence should be addressed to Bei B. Zhang bei_zhang@merck.com
Obesity and insulin resistance are major risk factors for a number of metabolic disorders, such as type 2 diabetes mellitus1, 2. Insulin has been suggested to function as one of the adiposity signals to the brain for modulation of energy balance. Administration of insulin into the brain reduces food intake and body weight3, 4, 5, and mice with a genetic deletion of neuronal insulin receptors are hyperphagic and obese6. However, insulin is also an anabolic factor; when administered systemically, pharmacological levels of insulin are associated with body weight gain in patients7. In this study, we investigated the efficacy and feasibility of small molecule insulin mimetic compounds8, 9 to regulate key parameters of energy homeostasis. Central intracerebroventricular (i.c.v.) administration of an insulin mimetic resulted in a dose-dependent reduction of food intake and body weight in rats, and altered the expression of hypothalamic genes known to regulate food intake and body weight. Oral administration of a mimetic in a mouse model of high-fat diet-induced obesity reduced body weight gain, adiposity and insulin resistance. Thus, insulin mimetics have a unique advantage over insulin in the control of body weight and hold potential as a novel anti-obesity treatment.

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

  • Faculty positions

    • The University of Alabama at Birmingham
    • Birmingham, Alabama, USA
  • Scientist, Enzymology

    • Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
    • Copenhagen 2200 Denmark
Competing financial interests
Figures & Tables
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2002 Nature Publishing Group | Privacy policy